Aviva has executed a successful U.K.-focused strategy, divesting non-core assets and acquiring Direct Line to strengthen its market position. Operational performance has improved, with rising profits, strong solvency, and increased cross-selling, supporting a 5.6% dividend yield above the FTSE 100 average. Dividend growth is expected to slow to low-to-mid single digits per share, as the Direct Line acquisition increased the share count by 14%.
Aviva PLC (LSE:AV.) reports full-year results on 5 March, and the headline number investors will be watching most closely is not the profit figure but the buyback.
Autonomous vehicles and AI-led platforms are not yet hitting earnings, but Barclays argues the market is only beginning to price in structural risk to a revenue pool that makes up 35–40% of global P&C. The AI debate has barely begun in insurance.
UBS has put Aviva PLC back at the top of its UK domestic life insurance preferences, arguing the insurer's year-to-date underperformance has opened what it sees as an attractive entry point despite renewed debate around the future profitability of motor insurance. The broker said the stock's lag reflects investor focus on the potential for autonomous vehicles to push premiums lower, a sensitivity UBS flagged given that around 25% of Aviva's business is motor insurance following its Direct Line acquisition.
BHRB, LUV and AVVIY made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 2, 2026.
AVVIY, BHRB and LUV made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 2, 2026.
Aviva PLC (LSE:AV.) has completed its strategic transformation in the UK following its agreed acquisition of Direct Line Group, and stockbroker Peel Hunt has pitched a 'buy' rating with a 755p target price.
Aviva PLC (LSE:AV.) is UBS's preferred UK life insurer pick versus Legal & General Group PLC (LSE:LGEN), with the broker also favouring Phoenix over L&G and M&G.
AVVIY, CAE and CHMG have been added to the Zacks Rank #5 (Strong Sell) List on January 7th, 2026.
AVVIY, CLMB and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 18, 2025.
Phoenix Group Holdings PLC (LSE:PHNX) was added to Aviva PLC (LSE:AV.) as one of UBS's top picks in the European insurance sector going into 2026.
Aviva is reiterated as a Buy, with a raised target price, reflecting improved business fundamentals and a de-risked investment case. Aviva benefits from a transformation strategy, the Direct Line acquisition, and robust growth ahead. With higher cost-saving initiatives and better visibility on EPS growth, we see upside. Valuation still lagging peers despite better growth. Our buy is then confirmed.